APMD (Apnimed) FCF Margin %: -149.94% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

APMD Apnimed Inc APMD
8 GF Score
Price $28.25
View Full Analysis

What is Apnimed FCF Margin %?

Apnimed APMD +4.17% 8 FCF Margin % is -149.94% as of Jun. 2026. GuruFocus rates APMD with a GF Score™ of 8/100. Among 976 Biotechnology companies, Apnimed ranks better than 57.38% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Apnimed's Free Cash Flow for the three months ended in Jun. 2026 was $-18.11 Mil. Apnimed's Revenue for the three months ended in Jun. 2026 was $12.08 Mil. Therefore, Apnimed's FCF Margin % for the quarter that ended in Jun. 2026 was -149.94%.

As of today, Apnimed's current FCF Yield % is -3.22%.

The historical rank and industry rank for Apnimed's FCF Margin % or its related term are showing as below:

APMD' s FCF Margin % Range Over the Past 10 Years
Min: -1376.42   Med: -789.38   Max: -202.33
Current: -39.14

During the past 2 years, the highest FCF Margin % of Apnimed was -202.33%. The lowest was -1376.42%. And the median was -789.38%.

APMD's FCF Margin % is ranked better than
57.38% of 976 companies
in the Biotechnology industry
Industry Median: -76.7 vs APMD: -39.14

Apnimed FCF Margin % Related Terms

Apnimed FCF Margin % Historical Data

* Premium members only.

The historical data trend for Apnimed's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apnimed FCF Margin % Chart

Apnimed Annual Data
Trend Dec24 Dec25
FCF Margin %
-1,376.42 -202.33

Apnimed Quarterly Data
Mar25 Jun25 Mar26 Jun26
FCF Margin % -908.72 -101.52 -23.36 -149.94

APMD vs SANA, CRVS, ODTX: FCF Margin % Comparison

For the Biotechnology subindustry, Apnimed's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Apnimed FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Apnimed's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Apnimed's FCF Margin % falls into.


APMD
8GF Score
Apnimed Inc APMD
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Apnimed FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Apnimed's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-77.832/38.467
=-202.33 %

Apnimed's FCF Margin for the quarter that ended in Jun. 2026 is calculated as

FCF Margin=Free Cash Flow (Q: Jun. 2026 )/Revenue (Q: Jun. 2026 )
=-18.113/12.08
=-149.94 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -149.94% mean?
Apnimed (APMD) has a FCF Margin % of -149.94% as of Jun. 2026. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Apnimed and its competitors. According to the industry distribution chart, Apnimed ranks #416 out of 976 companies in the Biotechnology industry, placing it in the top 42.6%.
Is Apnimed's FCF Margin % too high?
Apnimed's current FCF Margin % is -149.94%. Based on the distribution chart, Apnimed ranks #416 out of 976 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Apnimed has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Apnimed's FCF Margin % compare to SANA and CRVS?
According to the Biotechnology industry distribution chart, Apnimed ranks #416 out of 976 companies for FCF Margin %. This puts Apnimed in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Apnimed and its competitors. Apnimed's current FCF Margin % is -149.94%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Apnimed stock overvalued right now?
Apnimed (APMD) has a current FCF Margin % of -149.94%. The current FCF Margin % is -149.94%. Apnimed's overall GF Score™ is 8/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Apnimed (APMD), the current FCF Margin % is -149.94% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Apnimed Business Description

Address 39 John F. Kennedy Street, 4th Floor, Cambridge, MA, USA, 02138
Apnimed Inc is a late clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of novel oral therapies that address the neurobiology of sleep related breathing diseases. The company's flagship product candidate, AD109, or Oxnimbi, is an investigational, fixed-dose oral combination of a novel anti-muscarinic and selective norepinephrine reuptake inhibitor for the treatment of obstructive sleep apnea (OSA).
8GF Score

Get the complete analysis for APMD

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$28.25
Price